because of difficulties in reproducing our initial findings, we investigated the possibility that there might have been contamination by plasmid DNA derived from E. coli in the DNA preparations extracted from N. crassa. To determine whether this was the case, the DNAs from the original isolates were incubated with restriction endonuclease Bcl I and examined for specific restriction enzyme cleavage products. Southern blot analysis revealed that a substantial fraction of the plasmid present in these isolates was resistant to Bcl I digestion whereas the N. crassa genomic DNAs and inserted plasmid sequences were completely digested by RM I. Because Bcl I does not digest DNA that has been methylated by the E. coli dam methylase, we interpret this as evidence for plasmid contamination because there is no comparable DNA modification enzyme in N. crassa. Furthermore, in subsequent experiments using DNAs extracted from N. crassa transformants that show no evidence of contamination, we have failed to recover pDV1001 by transformation of E. coli. Although the fact that pDV1001 produces "abortive transformants" suggests that it carries an ars sequence, we now have no evidence to suggest that it is capable of sufficient stable autonomous replication without integration into the N. crassa genome to prove useful as a potential "shuttle" vector between N. crassa and E. coli.
Retraction. Recently, we published a paper entitled "Chimeric plasmid that replicates autonomously in both Escherichia coli and Neurospora crassa," by Karen Hughes, Mary E. Case, Robert Geever, Daniel Vapnek, and Norman H. Giles, which appeared in number 4 , February 1983, of Proc. Natl. Acad. Sci. USA (80, 1053-1057). However, because of difficulties in reproducing our initial findings, we investigated the possibility that there might have been contamination by plasmid DNA derived from E. coli in the DNA preparations extracted from N. crassa. To determine whether this was the case, the DNAs from the original isolates were incubated with restriction endonuclease Bcl I and examined for specific restriction enzyme cleavage products. Southern blot analysis revealed that a substantial fraction of the plasmid present in these isolates was resistant to Bcl I digestion whereas the N. crassa genomic DNAs and inserted plasmid sequences were completely digested by RM I. Because Bcl I does not digest DNA that has been methylated by the E. coli dam methylase, we interpret this as evidence for plasmid contamination because there is no comparable DNA modification enzyme in N. crassa. Furthermore, in subsequent experiments using DNAs extracted from N. crassa transformants that show no evidence of contamination, we have failed to recover pDV1001 by transformation of E. coli. Although the fact that pDV1001 produces "abortive transformants" suggests that it carries an ars sequence, we now have no evidence to suggest that it is capable of sufficient stable autonomous replication without integration into the N. crassa genome to prove useful as a potential "shuttle" vector between N. crassa and E.
coli.
Correction. The article "Bent helical structure in kinetoplast DNA" by Joan C. Marini, Stephen D. Levene, Donald M. Crothers, and Paul T. Englund, which appeared in number 24, December 1982, of Proc. NatI. Acad. Sci. USA (79, 7664-7668), reported the nucleotide sequence of a fragment of Leishmania tarentolae kinetoplast DNA. This sequence had been determined by J.C.M. and P.T.E. Subsequently, Drs. Stephan Dieckmann and James Wang of Harvard University initiated experiments on a recombinant plasmid containing this fragment. As part of their experiments they redetermined the sequence of the fragment and found that the published sequence contained substantial errors. After they informed us of the discrepancy, we (J.C.M. and P.T.E.) decided to redetermine the sequence. Our results, shown here in Fig. 1 MATERIALS AND METHODS Virus Leukemia and Cell Line. The I5 virus stock has been described (5) . This helper-independent ecotropic virus, Friend murine leukemia virus (F-MuLV), was isolated from the polycythemic Friend leukemia virus complex (Steeves-Lilly strain), free of any detectable spleen focus-forming virus (SFFV), xenoThe publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
ZUfrre >ALQ -Pr 0 c wwrl. A rJ 1 In Vivo Assay for Erythropoietic Activity. DBA2 female adult mice were rendered polycythemic (hematocrit, >60%) by injecting intraperitoneal packed erythrocytes (1 ml on day -4 and 0.5 ml on day -1). Erythropoietin (Connaught Laboratories, Toronto), saline, and culture supernatant were injected subcutaneously on day 04five animals in each experimental group).
On day 3 
In Vitro Assays for Normal Hematopoietic Progenitors. Colony-forming unit erythroid (cfu-e) assays were carried out in plasma clot cultures according to McLeod et al. (9) with few modifications (10) . Cultures were set up either with normal mouse bone marrow cells (2 x 105 per ml) or with normal human bone marrow cells (5 x 105 per ml). Briefly, assays were carried out in 35 x 10 mm Petri dishes (Falcon 3001) containing 0.2 ml of serum (see below), 0.1 ml of detoxified bovine serum albumin, 0.1 ml of L-asparagine (Calbiochem) (0.2 mg/ml)/amedium/CaCl2 (28 mg/100 ml), 0.1 ml of cell suspension, 0.1 ml of erythropoietin step 3 (Connaught Laboratories), and 0.3 ml of a-medium. In some cultures erythropoietin was omitted and replaced either by a-medium or by 0.45-0.9 ml of culture supernatant from IW.32 cells. Duplicate cultures were allowed to clot after addition of 0.1 ml of citrated bovine plasma (Flobio, Courbevoie, France). They were then incubated at 370C in humidified 5% C02/95% air. After incubation, clots were fixed with glutaraldehyde, stained with benzidine/hematoxylin, and scored for erythroid colonies. For murine cultures, fetal calf serum was used and incubation was for 60 hr. For human cultures, a pool of normal AB serum was used and incubation was for 7 days. Murine granulomacrophagic colony-forming unit assays were carried out in monolayer agar cultures as described by Metcalf (11) . Mouse bone marrow cells (7 x 104) were cultured in 1 ml of 0.3% agar/a-medium/10% fetal calf serum. Serum from mice previously injected with endotoxin (12) was used as a source of colony-stimulating factor. On day 7 In vivo, the inoculation of 1 ml of crude or 0.5 ml of concentrated (x 10) IW.32 supernatant in hypertransfused polycythemic mice induced a significant incorporation of 59Fe into circulating erythrocytes (Fig. 1) be estimated between 0.15 and 0.30 IU/ml of supernatant.
In vitro, IW.32 supernatant was added to the culture of normal murine bone marrow mononuclear cells instead of erythropoietin. It induced characteristic benzidine-positive erythroid colonies in plasma clot cultures after 60 hr (cfu-e derived) and 7 days (burst-forming unit erythroid derived). As little as 10 Al of supernatant per culture was sufficient to induce such colonies. Dose-response curves of normal murine bone marrow cfu-e to IW.32 supernatant and erythropoietin step 3 were strikingly similar, showing a linear increase in the number of cfu-e-derived colonies, followed by a plateau (Fig. 2) . However, the number of erythroid colonies at the plateau was significantly higher in the presence of IW.32 supernatant than with erythropoietin step 3. The erythropoietin equivalent activity could be estimated to range between 0.5 and 1 IU/ml of supernatant. IW.32 supernatant exhibited no granulomacrophagic colony-stimulating factor activity when added to normal mouse bone marrow cells in agar culture (data not shown). The in vitro erythropoietic activity of IW.32 was not species specific because IW.32 supernatant induced typical cfu-e-derived erythroid colonies at 7 days when added to human bone marrow mononuclear cells in plasma clot culture (use of 0.5 ml of IW.32 supernatant instead of erythropoietin induced 510 + 30 erythroid colonies per 5 x 1 bone marrow cells).
Biochemical Studies. Biochemical characteristics of IW.32 supernatant and erythropoietin step 3 were compared by testing the ability to induce murine bone marrow cfu-e-derived colonies after similar biochemical treatments. The biological activities of both erythropoietin step 3 and IW.32 supernatants were unaffected or only partially decreased by heating at 56°C for 30 min, by boiling at 100°C for 3 min, by freeze-drying and dialysis, or by treatment with trypsin (100 ,g/ml) for 1 hr at 37°C. They were abolished by trypsin at 200 ,ug/ml for 6 hr at 37°C (Table 2 ). IW.32 erythropoietic stimulating factor was precipitated by ammonium sulfate between 50% and 80% saturation (Table 3) . After concanavalin A-Sepharose chromatography the activities of both factors were eluted immediately after the void volume (Fig. 3) .
DISCUSSION
In this paper we describe the production of an erythropoietic factor by a murine erythroleukemia cell line. The erythroid differentiation ability of the leukemia cell line was shown by the induction of hemoglobin synthesis (checked by benzidine staining) after incubation with some biochemical compounds ( in vitro in the absence of erythropoietin, whereas such colonies were always found in bone marrow of the mice rendered polycythemic by the Friend virus polycythemic strain as described (13, 14) . (iii) The erythropoietic activity of IW.32 supernatants was stable at 100°C, a temperature known to destroy the infectivity of any type C virus.
The polycythemia observed in graft recipients could therefore be due to the secretion of an erythropoietic factor by the malignant IW. . IW.32 conditioned medium (20 ml) and erythropoietin (4 IU) diluted in a-medium/5% fetal calf serum (20 ml) were freeze-dried and dialyzed against starting buffer (Tris-buffered saline). Samples were applied to a concanavalin A-Sepharose column (0.9 x 2 cm) equilibrated in startingbuffer (flow rate, 10 ml/hr). Unretained proteins constituted pool A. Columns were washed with 35 ml of startingbuffer; the pool B proteins were removed by elution with 15 ml of 0.2 M a-methyl mannoside in starting buffer and the pool C proteins were removed by elution with 15 ml of 0.5 M a-methyl mannoside in starting buffer. Samples were dialyzed against Tris-buffered salixe (pH 7.4) before assay.
Proc. Natl. Acad. Sci. USA 80 (1983) I ity in vivo after treatment with neuraminidase (16) .
The IW.32 supernatant does not contain granulomacrophagic colony-stimulating factor activity. The production of other growth factors by this cell line is currently being investigated. It is already clear that the erythropoietic activity produced by the IW.32 cell line differed from erythropoietic factors that have been previously distinguished from erythropoietin. The erythropoietic burst-promoting activity has been defined as a substance necessary for the differentiation of early progenitors into cfu-e (17) . It was unable to trigger the differentiation of cfu-e into erythroblasts. In contrast, erythropoietin and the IW.32 factor induced in vitro mature erythroblastic colonies from murine bone marrow cells in 2 days. This does not rule out the presence in IW.32 supernatant of a burst-promoting activity together with the erythropoietin-like activity. The factor described by Johnson and Metcalf (18) can be ruled out because it is active only on hepatic erythroid progenitors of fetal mice and is inactive on adult bone marrow cells. Recently an erythropoietic factor has been described in the supernatant of splenocytes stimulated by allogeneic cells (19) . However, this factor was shown to differ from erythropoietin because it was retained on a concanavalin A-Sepharose column. This type of chromatography did not allow the distinction between erythropoietin and IW.32 erythropoietic activity.
In conclusion, the properties of the IW.32 cell lines are of importance for at least two reasons. (i) This is an example of a malignant cell line producing in vitro large amounts of a soluble factor very similar to erythropoietin. It will be necessary to determine whether or not leukemia cell growth is dependent on this factor. Indeed these malignant cells were shown to belong to the erythroid lineage, and other examples have already been described of malignant hematopoietic cell lines in which growth is autostimulated by factors similar to physiological growth factors (20, 21) . However, IW.32 is an example of an erythroid cell line producing an erythropoietic factor. We have been unable to find such an activity in three supernatants of erythroleukemia cell lines induced by the Friend virus complex. (ii) IW.32 cells appear as a potent source of an erythropoietin-like activity, which might be used, at least in vitro, to replace erythropoietin if its similarity to currently used erythropoietin is confirmed.
